Trials / Completed
CompletedNCT03343639
Study of the Efficacy, Safety and Tolerability of Serlopitant for the Treatment of Pruritus (Itch) With Plaque Psoriasis
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Pruritus in Adults With Plaque Psoriasis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 204 (actual)
- Sponsor
- Vyne Therapeutics Inc. · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Study of the efficacy, safety, and tolerability of serlopitant for the treatment of pruritus in adults with plaque psoriasis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 5 mg Serlopitant Tablets | Serlopitant Tablets |
| DRUG | Matching Placebo Tablets | Placebo Tablets |
Timeline
- Start date
- 2017-11-01
- Primary completion
- 2018-10-23
- Completion
- 2018-11-12
- First posted
- 2017-11-17
- Last updated
- 2021-05-20
- Results posted
- 2019-06-12
Locations
39 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03343639. Inclusion in this directory is not an endorsement.